IQVIA Holdings Inc. (NYSE:IQV), a global leader in advanced analytics, technology solutions, and clinical research services for the healthcare and life sciences industries, finds itself at a critical ...

Shares of IQVIA Holdings Inc. IQV slipped 1.12% to $199.11 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to 5,994.57 ...

BTIG analyst David Larsen downgraded Iqvia (IQV) to Neutral from Buy without a price target The firm says clinical research organization ...

Over the past year, many IQVIA Holdings Inc. ( NYSE:IQV ) insiders sold a significant stake in the company which ...

BTIG analyst David Larsen adjusted the firm's stance on IQVIA Holdings (NYSE:IQV), moving from a Buy rating to Neutral. The $36.5 billion market cap company, currently trading near its 52-week low at ...

Barclays lowered the firm’s price target on Iqvia (IQV) to $235 from $255 and keeps an Overweight rating on the shares. The firm says the life ...

While 118 biologics are expected to lose patent protection in the US over the next decade, that $234 billion opportunity for ...

GDS Wealth Management raised its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 8.4% during the 4th ...

Evaluate the expected performance of IQVIA (IQV) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics ...

Tokio Marine Asset Management Co. Ltd. grew its position in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 4.6% in the 4th ...

In addition, you can check the fund’s top 5 holdings to determine its best picks for 2024. Oakmark Select Fund highlighted stocks like IQVIA Holdings Inc. (NYSE:IQV) in the fourth quarter 2024 ...

IQVIA Holdings Inc. closed 22.27% below its 52-week high of $261.73, which the company achieved on March 8th.